CTTC News Alert Central Trust Co (CTTC) 0.2000 10/01/2014 09

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Central Trust Co (CTTC) 0.2000 $CTTC

Conrad F. Mir, CEO of Competitive Technologies (OTCQX: CTTC) to Be Interviewed LIVE on Clear Channel Business Talk Radio -- August 14th, 2014
Marketwire - Wed Aug 13, 6:15AM CDT
Competitive Technologies, Inc (OTCQX: CTTC) (CTI) announced today that Chief Executive Officer (CEO) Conrad F. Mir will be interviewed live tomorrow by host Michael Yorba on Clear Channel Business Talk Radio's The Traders Network Show. Mr. Mir will be discussing Competitive Technologies Inc., the pain mitigation company, which develops and commercializes innovative pain management products and technologies. CTI holds the 510k clearance on its flagship product, the non-invasive Calmare(R) Pain Therapy Device. CTI is the exclusive licensed global distributor of Calmare.

Competitive Tech Brings Sales Management Position In-house
PR Newswire - Mon Aug 11, 1:22PM CDT
Competitive Technologies, Inc., (OTCQX: CTTC) (CTI), names William Lipford, the current Midwest Regional Sales Manager for CTI, U.S. division head of product sales. In his new role, he will be responsible to direct all U.S. sales of CTI's flagship product, the Calmare® Pain Therapy device, and oversee the expansion of CTI's independent, distributor sales force across the United States.

SeeThruEquity Initiates Coverage on Competitive Technologies (OTCQX:CTTC) with a Speculative Buy Rating - Video Research Alert on InvestmentPitch.com
Thomson Reuters ONE - Thu Jul 03, 9:36AM CDT
Vancouver, BC, July 3, 2014 - New York-based SeeThruEquity has initiated coverage on Competitive Technologies (OTCQX:CTTC). Analyst Brandon Primack gives the company a speculative buy rating, and a target price of $0.79, a premium of 147% to the $0.32 price on June 26th, the day the report was issued.

Judge Ruling Favors Calmare® Pain Therapy Reimbursement In Personal Injury Case Against Allstate Insurance Co.
PR Newswire - Mon Jun 30, 8:32AM CDT
The Calmare® Pain Therapy Device, the flagship product of Competitive Technologies, Inc., (OTCQX: CTTC) (CTI), the pain mitigation company, gained a favorable reimbursement ruling from the New York City Civil Courts in a personal injury case against Allstate Insurance, Co., (Allstate). In the ruling, the Court instructed the insurance giant to reimburse Forest Rehabilitation Medicine P.C. (Forest) for its use of Calmare pain therapy (Calmare) on patients who suffer pain as a result of car accident injuries.

SeeThruEquity Initiates Research Coverage on Competitive Technologies Inc. with Target Price of $0.79
ACCESSWIRE - Thu Jun 26, 8:02AM CDT
New York, NY / ACCESSWIRE / June 26, 2014 / SeeThruEquity, a leading independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced that it has initiated coverage on Competitive Technologies Inc. (OTCQX: CTTC), a pain mitigation company with innovative wound and pain management products and technologies.

Competitive Tech To Sell Into Europe, The Middle East And North Africa
PR Newswire - Wed Apr 02, 9:15AM CDT
Competitive Technologies, Inc., (OTCQX: CTTC) (CTI), a pain mitigation company, will sell into Europe, the Middle East and North Africa (the "EMENA territory" effective immediately, in an effort to reestablish the global footprint that was compromised by the signing of the 2012 Amended Distribution and Sales Agreement (the "Amendment" between the inventor and the Company.

East Idaho Interventional Pain Center Now Offering The Calmare® Pain Therapy Device Treatments
PR Newswire - Thu Mar 27, 9:58AM CDT
Patients living with chronic neuropathic and oncologic pain in the Idaho Falls region can now count on a new arsenal in the fight against these conditions. The medical team at East Idaho Interventional Pain Center is now offering a non-invasive approach to their patients with the addition of the Calmare® Pain Therapy Device treatments as part of the suite of procedures offered at the center.

New Study Results: Calmare® Pain Device Therapy May Reduce Chemotherapy-Induced Pain Scores By About 30%
PR Newswire - Tue Mar 25, 9:30AM CDT
The results of a recently published, single-arm clinical study in the Journal of Pain and Palliative Care Pharmacotherapy, (December 2013) demonstrated how a cohort of 39 chronic, chemotherapy- induced peripheral neuropathy (CIPN) patients experienced an average pain score reduction of 31.8% in their level of chronic pain undergoing Calmare® Pain Device therapy - Competitive Technologies, Inc., (OTCQX: CTTC) (CTI) flagship medical product.

Competitive Tech Names Former "Big Pharma" Sales Executive U.S. Division Head of Product Sales
PR Newswire - Wed Mar 05, 8:14AM CST
Competitive Technologies, Inc., (OTCQX: CTTC) (CTI), names Joel Bradus, former "Big Pharma" sales executive, U.S. division head of product sales. Mr. Bradus was appointed with the full responsibility of steering and expanding the Calmare products sales force in the United States.

Pipeline Mosque Inaugurates Africell-Sponsored Minaret
All Africa Global Media - Tue Feb 25, 11:05AM CST
The Pipeline Mosque on Friday inaugurated its new 33.35 meters minaret, reportedly sponsored by Africell GSM Company to the tune of D1 million.

Noka Resources Closes Oversubscribed Second Tranche of Financing
Marketwire - Tue Feb 25, 8:05AM CST
Noka Resources Inc. (TSX VENTURE: NX)(FRANKFURT: 2NK) (the "Company" is pleased to announce that, further to the Company's news release dated February 6, 2014 whereas the Company closed $597,500 of the Non-Brokered Private Placement financing (the "Financing" , the Company has closed the second tranche of the Financing for additional gross proceeds of $536,000, bringing the total amount raised to $1,133,500.

Competitive Tech Slated To Present At The See Thru Equity Winter Microcap Investor Conference
PR Newswire - Wed Feb 05, 2:25PM CST
Competitive Technologies, Inc., (OTCQX: CTTC) (CTI), the pain mitigation company, is slated to present at the SeeThruEquity Winter Microcap Investor Conference on Thursday, February 6, 2014, at 1:30 PM EST.

WNS (Holdings) Beats Fiscal Q3 Earnings, Revs Up Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jan 16, 1:10PM CST
WNS (Holdings) reported operating net earnings of 38 cents per share for fiscal third-quarter 2014 ending Dec 31, 2013, beating the Zacks Consensus Estimate.

Competitive Tech's Calmare® Pain Device Therapy Garners Favorable Medicare Coverage Judgment
PR Newswire - Wed Jan 15, 9:35AM CST
Competitive Technologies, Inc., (OTCQX: CTTC) (CTI), a biotechnology company, received a favorable Medicare treatment coverage judgment for its flagship medical technology device, the Calmare® pain therapy medical device, stemming from an appeal filed by an authorized Calmare practitioner in Staten Island, the Physical Medicine and Rehabilitation Associates of Staten Island, LLP (collectively, the Calmare Pain Relief Solutions or CPRS), by and through, Christopher M. Perez, M.D. U.S. Administrative Law Judge LeAnn R. Canter allowed the appeal, which resolved claims for Medicare coverage for a named Medicare enrollee (Beneficiary). The appeal allows CPRS to receive reimbursements for treatments using the Calmare Therapy for claims made in behalf of beneficiary.

Competitive Technologies Announces Financial Results for the Six Months Ended June 30, 2013
GlobeNewswire - Tue Aug 13, 1:14PM CDT
Competitive Technologies, Inc. (OTCQX:CTTC) announced today its financial results for the six months ended June 30, 2013. Revenues for the first half of 2013 were $0.2 million and expenses were $1.7 million producing a net loss for the first half of 2013 of $1.5 million.

Forest Rehabilitation Medicine PC Opens Sixth Clinic Utilizing Calmare/Scrambler Chronic Pain Therapy on Staten Island and Brooklyn
Marketwire - Thu Jun 27, 7:33AM CDT
Forest Rehabilitation Medicine PC a chronic pain treatment medical practice with multiple locations on Staten Island and now in Brooklyn, announced today the opening of its sixth clinic at the offices of Daniel W. Wilen, MD, Board-certified Orthopedic Surgeon, at 9202 Fort Hamilton Parkway, Brooklyn, New York 11209, using Calmare/Scrambler Therapy, a non-invasive and non-narcotic therapy for the treatment of chronic neuropathic pain.

Competitive Technologies, Inc. Announces Sales of Its Calmare(R) Pain Therapy Medical Device
GlobeNewswire - Tue Jun 25, 9:43AM CDT
Competitive Technologies, Inc. (OTCQX:CTTC) today announced two recent sales of Calmare medical devices, one to a military hospital and one to a physician practice, both located in the Northwest region of the United States.

Competitive Technologies Shareholders Elected Directors at Annual Shareholder Meeting
GlobeNewswire - Thu Jun 20, 10:44AM CDT
Competitive Technologies Inc. (OTCQX:CTTC) held its annual meeting of shareholders earlier today at the Norwalk Inn and Conference Center in Norwalk, Conn. CTTC's Chairman, Peter Brennan conducted the business meeting and President and Chief Executive Officer, Carl O'Connell, provided an overview of the Company's plans.

Competitive Technologies, Inc. Announces Presentation at American Urological Association
GlobeNewswire - Wed Jun 19, 2:49PM CDT
Competitive Technologies, Inc. (OTCQX:CTTC) today announced an update regarding Xion Pharmaceuticals ("Xion" , a joint venture with CTTC formed in 2010 to advance the commercialization of Melanotan-II (MT-II) peptides especially for sexual dysfunction.

Competitive Technologies Announces Financial Results for Quarter Ended March 31, 2013
GlobeNewswire - Wed Jun 19, 1:16PM CDT
Competitive Technologies, Inc. (OTCQX:CTTC) announced today its financial results for the first quarter 2013. Revenues for the quarter were $0.06 million and expenses were $0.8 million producing a net loss for the quarter of $0.8 million.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Iberostar's Grand Move: Opening in Zanzibar

Updated Category News Views 175

The Resort That Takes Your Breath Away Here we have Iberostar, boldly wading into the azure waters of the Indian Ocean, planting its flag on the sandy beaches of Zanzibar. This isn’t just another notch on the resort’s belt—it’s their first time setting up shop in East Africa, a move ripe with promise and adventure both. A Suite So Sweet 358 suites, mind you. Each...

Continue Reading
Vuzix Bets on Lightweight Color Glasses for OEM Partners

Updated Category News Views 34

Forty grams is where this story gets interesting, because faces are ruthless product testers. People will tolerate plenty of clever technology right up until it pinches, looks goofy, leaks light, or makes them feel like they are wearing a science project. Vuzix is trying to clear that hurdle with Ultralite Color, a full-color AI eyewear reference platform built for OEM...

Continue Reading
Yeahka Bids to Lead AI Shopping Evolution

Updated Category News Views 115

AI Shopping: A New Frontier or A Sisyphean Task? The evolution of AI from sassy recommendation tools to transaction-executing agents is shaking up the retail sector. Enter Stage Left: Yeahka Limited (9923.HK), a payment tech outfit that's wading into this murky digital swamp. With YeahPay and Fushi Tech, they're trying to hammer out a blueprint for AI-friendly commerce...

Continue Reading
Sunbit’s 2027 Loan Push Meets an NVIDIA-Fueled Tape

Updated Category News Views 16

Credit Is About to Enter Sunbit’s Growth Story Sunbit has spent years building a point-of-sale fintech footprint, and the numbers it cited on November 18 make the next step harder to dismiss as mere marketing fluff. The company says it has topped 400,000 activated cardholders and 50,000 merchants, while expecting more than $440 million in fiscal 2026 sales on greater...

Continue Reading
USFM's Disko Deal Waits on Greenland Until March 2027

Updated Category News Views 211

A missing Greenland signature has turned USFM’s grand Disko plan into a calendar problem. Nothing more dramatic has been disclosed, but nothing less consequential should be assumed either. March 31 replaces a deadline that already failed USFM executed its share purchase agreement with 80 Mile PLC and Disko Exploration Limited on May 8, 2026. The proposed bargain is...

Continue Reading
Voranigo Follow-Up Deepens the Glioma Care Debate Today

Updated Category News Views 159

Brain-tumor progress rarely arrives with a clean victory lap, but the longer INDIGO readout gives clinicians and sector watchers something sturdier than a one-time headline. Servier presented extended Phase 3 results for VORANIGO, or vorasidenib, at the Society for Neuro-Oncology meeting in Philadelphia on November 14 and 15, 2026. The central message is durable benefit...

Continue Reading
Albany Masonry Waterproofing Is a Quiet Value Play

Updated Category News Views 0

Winter works its mischief one soaked brick at a time. That is the unglamorous truth behind Sean Mulligan's discussion of masonry waterproofing for Albany-area homes. Brick and stone look tough enough to outlast the furniture, the siding, maybe the whole neighborhood. Yet they are porous materials, and in a region where rain, snowmelt, and sharp temperature swings keep...

Continue Reading
Teen Adoption Campaign Makes Room for Mutual Growth

Updated Category News Views 120

A bicycle wobble and a ballet count carry more weight than they first appear to. The new Adoption from Foster Care public service ads put teens in the instructor's spot: a son helps his mother learn to ride a bike in Two Wheeler, while a daughter walks her father through ballet in Routine. It is a small creative reversal, but a smart one. Teen adoption is too often framed...

Continue Reading
Linkind's Best Buy Push Tests Smart Outdoor Demand

Updated Category News Views 77

Holiday lights have quietly become a year-round hardware category, and Linkind wants a louder seat at the table. The smart-lighting brand says three outdoor products have been in Best Buy stores across the United States since October 17, 2026: permanent exterior lights, decorative string lights, and solar pathway lights. That is a real distribution step, not some grand...

Continue Reading
Weatherford Adds Grant Roach to Its Sports Deal Team

Updated Category News Views 0

Sports investing has reached that awkward middle age where everybody sees the runway, but few can explain exactly where the bumps are. Weatherford Capital’s decision to bring Grant Roach aboard as vice president is not a headline packed with transaction fireworks. It is, however, a pretty clear tell: the Tampa firm intends to put more bodies and more underwriting muscle...

Continue Reading

Top 5 Most Recently Viewed Articles

Siton Mining Leads Global Cloud Mining Revolution Amid XRP Surge

Updated Category News Views 209

XRP Makes Waves in the Cryptocurrency Market The cryptocurrency market is no stranger to volatility, but recent events have made headlines globally. XRP has soared past the $3.6 mark, capturing the attention of investors eager for a piece of this booming digital asset. The crypto sphere is evolving rapidly, and this surge reflects a momentous shift in the financial...

Continue Reading
Amgen's UPLIZNA Shows Great Promise for Myasthenia Gravis

Updated Category News Views 139

Amgen’s UPLIZNA Demonstrates Promise in Myasthenia Gravis Trials Amgen (NASDAQ: AMGN) has recently announced encouraging results from its Phase 3 MINT trial involving UPLIZNA (inebilizumab-cdon), aimed at treating adults with generalized myasthenia gravis (gMG). These findings were unveiled at a prominent conference, demonstrating substantial improvements in the daily...

Continue Reading
Waterton and The NRP Group Expand Luxury Rental Market

Updated Category News Views 371

Strategic Partnership for Luxury Living Waterton, a well-known real estate investor, has collaborated with The NRP Group, a leader in multifamily housing development, to create an exciting rental community just south of the Las Vegas Strip. The new project will feature 368 luxury units designed to provide modern amenities and greater access to employment opportunities in...

Continue Reading
KinderCare Learning IPO Faces Serious Allegations and Investor Impact

Updated Category News Views 211

Investigation into KinderCare Learning's IPO and Allegations KinderCare Learning Companies, Inc. (KLC) is currently facing a significant legal challenge as a securities class action lawsuit has been filed alleging serious issues related to the company's recent IPO. This legal battle, known as Gollapalli v. KinderCare Learning Companies, Inc., et al., raises questions not...

Continue Reading
NovaMeme Emerges with Strategic Partnership for Growth

Updated Category News Views 235

NovaMeme Rebrands and Partners with Toobit for Expansion NovaSeeds has officially transformed into NovaMeme, marking a pivotal shift aimed at enhancing the crypto trading landscape. This rebranding aligns seamlessly with their strategic collaboration with Toobit, a well-respected centralized exchange renowned for its comprehensive crypto trading services including Spot...

Continue Reading